Ipramid 250 mcg/ml (Respirator Solution)

20 ml bottle: ৳ 130.00

Medicine Details

Category	Details
Generic	Ipratropium bromide
Company	Beximco pharmaceuticals ltd
Also available as	Ipramid 20 mcg inhaler

Reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD)
Reversible airway obstruction in asthma
Treatment of chronic reversible airway obstruction

Ipratropium Bromide is a quaternary ammonium compound with anticholinergic properties.

Nebuliser Solution:
- Adults and children over 12 years: 250-500 micrograms 3 to 4 times daily
- Children 6-12 years: 250 micrograms up to 1 mg daily
- Children 0-5 years (for acute asthma): 125-250 micrograms up to 1 mg daily
- Adult inhaler dose: 1-2 puffs 3 or 4 times daily

Nebuliser Solution: Should be combined with a short-acting beta 2-agonist in the same nebulizer chamber.
Inhaler: Steps for effective usage and cleaning

Ipramid has been used concomitantly with sympathomimetic bronchodilators, methylxanthines, steroids without adverse reactions.

Hypersensitivity to atropine or its derivatives
Hypersensitivity to Ipratropium or its derivative
Hypersensitivity to soya lecithin or related food products such as soybean, lecithin and peanut

Nebuliser Solution:
- Common: Headache, Dizziness, Cough, Dryness of mouth, Vomiting
- Uncommon: Urticaria, Tachycardia, Skin rash
- Inhalation induced bronchospasm
Inhaler:
- Potentially life-threatening effects are rare
- Severe/Irreversible adverse effects are not reported

Safety during human pregnancy not established. Caution during nursing.

Nebuliser Solution: Use under close medical supervision, caution in patients with narrow-angle glaucoma or prostatic hyperplasia
Inhaler: Temporary blurring of vision, Avoid spraying into eyes, Not indicated for initial treatment of acute episodes

Acute overdosage by inhalation is unlikely as Ipramid is not well absorbed systemically.